GLP-1, or {glucagon-like|glucagon like|glucagon) peptide-1, is rapidly emerging as a major focus in medical research, largely due to its notable impact on controlling diseases such as adult-onset diabetes and obesity. Ongoing research have demonstrated that beyond glucose control, GLP-1 drugs offer promise for cardiovascular health and possibly … Read More